Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy
Clinical trial NCT02966730 · TERMINATED
Trial details
- NCT number
- NCT02966730
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-06-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.